Executive Function and Attention Performance in Children with ADHD: Effects of Medication and Comparison with Typically Developing Children
| Autor: | Judit Futo, Martina Miklós, Dániel Komáromy, Judit Balazs |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Male
Future studies Health Toxicology and Mutagenesis medicine.medical_treatment Psychological intervention lcsh:Medicine Neuropsychological Tests attention-deficit/hyperactivity disorder behavioral disciplines and activities Article Executive Function 03 medical and health sciences Typically developing Child Development 0302 clinical medicine children mental disorders Humans ADHD Medicine Effective treatment Attention deficit hyperactivity disorder 0501 psychology and cognitive sciences Child KiTAP Mini-international neuropsychiatric interview business.industry lcsh:R 05 social sciences typical development Public Health Environmental and Occupational Health executive functions medicine.disease Executive functions EF attention Stimulant Treatment Outcome Attention Deficit Disorder with Hyperactivity Central Nervous System Stimulants Female medication business 030217 neurology & neurosurgery 050104 developmental & child psychology Clinical psychology |
| Zdroj: | International Journal of Environmental Research and Public Health Volume 16 Issue 20 International Journal of Environmental Research and Public Health, Vol 16, Iss 20, p 3822 (2019) |
| ISSN: | 1660-4601 |
| Popis: | The emerging literature reports that children with Attention-Deficit/Hyperactivity Disorder (ADHD) show deficits in executive functioning. To date, the combination of drug therapy with certain evidence-based non-medication interventions has been proven to be the most effective treatment for ADHD. There is a gap in the literature regarding comparing the executive functions (EF) of treatment naï ve and medicated children with ADHD with both each other and typically developing children. Altogether, 50 treatment naï ve and 50 medicated children with ADHD and 50 typically developing children between the ages of six and 12 were enrolled. The Mini International Neuropsychiatric Interview for Children and Adolescents (Mini Kid) and the Test of Attentional Performance for Children (KiTAP) measures were employed. Treatment naï ve children with ADHD showed weaker performance on most executive function measures (12 out of 15) than either the medicated ADHD group or the controls. There were no significant differences between the medicated ADHD children and typically developing children in most KiTAP parameters (10 out of 15). Executive function impairments were observable in treatment naï ve ADHD children, which draws attention to the importance of treating ADHD. Future studies should focus on the specific effects of stimulant medication on executive functions. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|